Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
1928ZT-2 by Wellington Zhaotai Therapies for Lymphoma: Likelihood of Approval
1928ZT-2 is under clinical development by Wellington Zhaotai Therapies and currently in Phase I for Lymphoma. According to GlobalData, Phase...
Data Insights
1928ZT-2 by Wellington Zhaotai Therapies for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
1928ZT-2 is under clinical development by Wellington Zhaotai Therapies and currently in Phase I for B-Cell Acute Lymphocytic Leukemia (B-Cell...